null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Concizumab ELISA Kit (GXEL00109)

SKU GXEL00109
Product Type ELISA Kit
Assay Type Quantitative
Detection Method Colorimetric
Sensitivity 0.156 μg/ml
Range 0.31-5 μg/mL
Size 96T
Synonyms Anti-TFPI, NN7415, mab2021, 1312299-39-0
€880
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Concizumab ELISA Kit

Assay Genie's Concizumab ELISA Kit (SKU: GXEL00109) provides researchers with a reliable quantitative ELISA for the quantitative measurement of Concizumab in Plasma, Serum. Offering a measurement range of 0.31-5 μg/mL and a sensitivity of 0.156 μg/ml, the kit is optimised for precision and ease of use in the research laboratory.

Concizumab (mAb 2021) is a high-affinity, humanized, monoclonal IgG4 antibody (mAb) developed by Novo Nordisk A/S. It was directed against the Kunitz-2 domain of human tissue factor (TF) pathway inhibitor (TFPI), designed to target and selectively block the factor X (FX) a (FXa) binding site of TFPI. As a mAb, concizumab has the advantage of being administered subcutaneously, and exhibits good solubility and stability, allowing administration as a liquid formulation via a ready- and easy-to-use portable pen device. Phase 2 trials of concizumab are ongoing for Haemophilia A and B. On 12 October 2017, orphan designation (EU/3/17/1940) was granted by the European Commission to Novo Nordisk A/S, Denmark, for concizumab for the treatment of haemophilia B.

Complete with standards, buffers and detection reagents, the Concizumab ELISA Kit streamlines assay set-up so you can focus on results. Choose the Concizumab ELISA Kit from Assay Genie for quality you can trust.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose